Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Submitted by
admin
on April 4, 2018 - 9:08am
Source:
Drug Delivery Business News
News Tags:
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Headline:
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Do Not Allow Advertisers to Use My Personal information
